Stock listing
Frankfurt:8QQ AbCellera Biologics Inc. Aktie
German listing (Frankfurt) of AbCellera Biologics Inc. · home listing NASDAQ:ABCL
Follow AbCellera Biologics Inc. into a list and get an email when it puts out news.
Share price · FWB:8QQ
€11.30 EUR +0.02 (+0.2%)
Close on Oct 30, 2026
- Day range
- €11.30 – €11.30 EUROct 30, 2026
- Market cap
- €3.66B EURAt the close on Oct 30, 2026 · price × 324.0M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ABCL · Home | $11.12 USD | -1.15 (-9.4%) | 3,026,401 | $12.27 | $12.29 | $11.05 | $12.27 | Close on Nov 2, 2026 |
| Frankfurt:8QQ | €11.30 EUR | +0.02 (+0.2%) | — | €11.30 | €11.30 | €11.30 | €11.28 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:8QQ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 22, 2026
AbCellera to Present at Upcoming Investor Conferences in November 2026
Latest earnings call · Aug 5, 2026
Abcellera Biologics (NASDAQ:ABCL) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 10, 2026
Technical Presentation (August 2026)
Technical · 19 slides
Calls
Upcoming
Abcellera Biologics (NASDAQ:ABCL) Q3 2026 Earnings Call
Mon, Nov 09, 2026 · 6:00 PM ET
Register
Replays
Abcellera Biologics (NASDAQ:ABCL) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 5:00 PM ET
Watch TranscriptAbcellera Biologics (NASDAQ:ABCL) Q1 2026 Earnings Call
Mon, May 11, 2026 · 5:00 PM ET
Watch TranscriptAbcellera Biologics (NASDAQ:ABCL) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Financings
Public offering of common shares and pre-funded warrants
Aug 13, 2026
Update: about US$200M · US$9.75 a share · Jefferies +4
Dealers: Jefferies (co-lead), J.P. Morgan (co-lead), Cantor (co-lead), UBS Investment Bank (co-lead), BMO Capital Markets (co-lead)
Use of proceeds: Research, development and clinical advancement of its internal pipeline including lead program ABCL635, working capital and general corporate purposes
Decks
Technical Presentation (August 2026)
Technical · 19 slides · Aug 10, 2026
Q2 2026 Earnings Presentation
Earnings · 13 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 24 slides · May 11, 2026
Q1 2026 Earnings Presentation
Earnings · 32 slides · May 11, 2026
AbCellera Biologics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 161 in all · newest Oct 22, 2026 · oldest 2020
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 5, 2026
- Decks
- 38 decks · latest Aug 10, 2026
Where AbCellera Biologics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ABCL · Home listing | NASDAQ | United States | USD |
| gettex:8QQ | gettex | Germany | EUR |
| Tradegate:8QQ | Tradegate | Germany | EUR |
| LS Exchange:A2QKXS | LS Exchange | Germany | EUR |
| BOATS:ABCL | BOATS | United States | USD |
| Lang & Schwarz:A2QKXS | Lang & Schwarz | Germany | EUR |
| Frankfurt:8QQ · This page | Frankfurt | Germany | EUR |
| BX Swiss:ABCL | BX Swiss | Switzerland | CHF |
| Dusseldorf:8QQ | Dusseldorf | Germany | EUR |
| Hamburg:8QQ | Hamburg | Germany | EUR |
| Munich:8QQ | Munich | Germany | EUR |
| Stuttgart:8QQ | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about AbCellera Biologics Inc.